These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 9699642)

  • 1. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
    Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
    Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells.
    Perkins C; Kim CN; Fang G; Bhalla KN
    Cancer Res; 1998 Oct; 58(20):4561-6. PubMed ID: 9788601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells.
    Ibrado AM; Liu L; Bhalla K
    Cancer Res; 1997 Mar; 57(6):1109-15. PubMed ID: 9067280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
    Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis.
    Perkins CL; Fang G; Kim CN; Bhalla KN
    Cancer Res; 2000 Mar; 60(6):1645-53. PubMed ID: 10749135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis.
    Kim CN; Wang X; Huang Y; Ibrado AM; Liu L; Fang G; Bhalla K
    Cancer Res; 1997 Aug; 57(15):3115-20. PubMed ID: 9242435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.
    Fontana JA; Sun RJ; Rishi AK; Dawson MI; Ordónez JV; Zhang Y; Tschang SH; Bhalla K; Han Z; Wyche J; Poirer G; Sheikh MS; Shroot B; Reichert U
    Oncol Res; 1998; 10(6):313-24. PubMed ID: 9848102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Loop' domain deletional mutant of Bcl-xL is as effective as p29Bcl-xL in inhibiting radiation-induced cytosolic accumulation of cytochrome c (cyt c), caspase-3 activity, and apoptosis.
    Burri SH; Kim CN; Fang G; Chang BS; Perkins C; Harris W; Davis LW; Thompson CB; Bhalla KN
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):423-30. PubMed ID: 10030271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein.
    Ponnathpur V; Ibrado AM; Reed JC; Ray S; Huang Y; Self S; Bullock G; Nawabi A; Bhalla K
    Clin Cancer Res; 1995 Nov; 1(11):1399-406. PubMed ID: 9815937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.
    Ibrado AM; Huang Y; Fang G; Bhalla K
    Cell Growth Differ; 1996 Aug; 7(8):1087-94. PubMed ID: 8853905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells.
    Bullock G; Ray S; Reed J; Miyashita T; Maria Ibrado A; Huang Y; Bhalla K
    Clin Cancer Res; 1995 May; 1(5):559-64. PubMed ID: 9816016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells.
    Ibrado AM; Kim CN; Bhalla K
    Leukemia; 1998 Dec; 12(12):1930-6. PubMed ID: 9844922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis.
    Wang S; Wang Z; Boise L; Dent P; Grant S
    Biochem Biophys Res Commun; 1999 May; 259(1):67-72. PubMed ID: 10334917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein.
    Bullock G; Ray S; Reed JC; Krajewski S; Ibrado AM; Huang Y; Bhalla K
    Leukemia; 1996 Nov; 10(11):1731-40. PubMed ID: 8892676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.
    Wang S; Vrana JA; Bartimole TM; Freemerman AJ; Jarvis WD; Kramer LB; Krystal G; Dent P; Grant S
    Mol Pharmacol; 1997 Dec; 52(6):1000-9. PubMed ID: 9396780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells.
    Tang C; Willingham MC; Reed JC; Miyashita T; Ray S; Ponnathpur V; Huang Y; Mahoney ME; Bullock G; Bhalla K
    Leukemia; 1994 Nov; 8(11):1960-9. PubMed ID: 7526093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
    Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
    Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells.
    Huang Y; Sheikh MS; Fornace AJ; Holbrook NJ
    Oncogene; 1999 Jun; 18(23):3431-9. PubMed ID: 10376521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels.
    Tudor G; Aguilera A; Halverson DO; Laing ND; Sausville EA
    Cell Death Differ; 2000 Jun; 7(6):574-86. PubMed ID: 10822281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.